Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesVentriPoint Diagnostics Ltd

VentriPoint Diagnostics Ltd

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.07 CAD -0.01 ( 6.67%)
Last update at 2026-11-04T14:30:00Z
VOLUME
1317
Market Cap
18.92M

Momentum Score

…

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.07
Low
0.07
High
52 Week Price Range
0.08
Low
0.18
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

VentriPoint Diagnostics Ltd is a Canada-listed medical technology company developing non-invasive cardiac imaging tools aimed at assessing right-heart function and pulmonary pressures for congenital heart disease and pulmonary hypertension. Long-term growth may be supported by clinical adoption, regulatory clearances and commercial partnerships, and investors may find the company attractive for addressing a targeted clinical need that could reduce invasive procedures.

The most important investment risks are early-stage commercialisation, limited public financial disclosure, regulatory and reimbursement uncertainty and potential need for additional capital to support trials and market expansion.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.07
Dividend Yield
-
Revenue TTM
0.18M
Revenue Per Share
0.00
Gross Profit TTM
0.18M
Debt / Equity
1.45
ROE
-2972.60%
Net Debt
1.35M
ROCE
173.38%
Diluted EPS TTM
-0.03

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -5.00M -4.87M -4.87M -3.88M -1.85M
Net income -4.92M -4.87M -4.87M -3.88M -1.85M
Selling general administrative 3.93M 2.81M 3.06M 2.67M 1.49M
Selling and marketing expenses - 1.08M 0.81M 0.54M 0.12M
Gross profit 0.10M -0.02M 0.06M -0.05M 0.03M
Reconciled depreciation 0.06M 0.07M 0.05M 0.05M 0.05M
Ebit - -4.93M -4.78M -3.59M -1.65M
Ebitda - -4.86M -4.73M -3.54M -1.59M
Depreciation and amortization - 0.07M 0.05M 0.05M 0.05M
Operating income -4.80M -4.93M -4.91M -3.72M -1.89M
Other operating expenses - 4.98M 4.98M 3.72M 1.93M
Interest expense 0.18M 0.06M 0.03M 0.01M 0.23M
Tax provision -0.08M - - - -
Interest income 0.01M 0.08M 0.03M 0.05M 0.01M
Net interest income -0.18M 0.01M -0.01M 0.03M -0.22M
Income tax expense - 0.00M 0.14M 0.09M 0.46M
Total revenue 0.10M 0.05M 0.07M 0.00M 0.04M
Total operating expenses 4.90M 4.91M 4.97M 3.72M 1.92M
Cost of revenue 0.00M 0.07M 0.01M 0.05M 0.01M
Total other income expense net -0.02M 0.06M 0.05M -0.20M 0.26M
Net income from continuing ops -4.92M -4.87M -4.87M -3.88M -1.85M
Net income applicable to common shares - - - - -1.85M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 0.66M 1.88M 5.98M 9.54M 0.80M
Other current assets - 0.06M - - -
Total liab 3.64M 1.69M 1.42M 1.21M 3.15M
Total stockholder equity -2.98M 0.19M 4.55M 8.33M -2.35M
Other current liab - 0.45M - - 0.00M
Common stock - 42.68M - - 31.01M
Capital stock 43.78M 42.68M 42.68M 42.21M 31.01M
Retained earnings -58.41M -53.49M -48.62M -43.75M -39.87M
Cash 0.06M 1.29M 5.19M 9.27M 0.53M
Total current liabilities 3.43M 1.40M 1.06M 1.09M 1.82M
Current deferred revenue - 0.03M - - -
Net debt 1.35M -1.02M - - 0.77M
Short term debt - 0.06M - - -
Short long term debt 1.36M 0.06M 0.05M - -
Short long term debt total - 0.27M - - -
Other stockholder equity - 10.91M - - 0.11M
Property plant equipment - - - - 0.09M
Total current assets 0.47M 1.64M 5.66M 9.50M 0.71M
Net tangible assets - - - - -2.35M
Net receivables 0.03M 0.29M 0.04M - 0.17M
Long term debt 0.06M 0.08M 0.09M 0.13M 1.29M
Inventory - - - - 0.00M
Accounts payable 1.70M 0.86M 0.84M 0.99M 1.01M
Accumulated other comprehensive income - 0.09M - - -
Non current assets total 0.18M 0.25M 0.31M 0.04M 0.09M
Capital lease obligations 0.22M 0.27M 0.32M 0.03M 0.08M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - - 0.00M -0.00M -0.00M
Change to liabilities - - - - 0.15M
Total cashflows from investing activities - - - - -0.00M
Net borrowings 1.52M - - - 1.16M
Total cash from financing activities 2.20M -0.10M 0.09M 11.89M 1.62M
Change to operating activities - - - - 0.04M
Net income -4.92M -4.87M -4.87M -3.88M -1.85M
Change in cash -1.23M -3.89M -4.08M 8.74M 0.51M
Begin period cash flow 1.29M 5.19M 9.27M 0.53M 0.01M
End period cash flow 0.06M 1.29M 5.19M 9.27M 0.53M
Total cash from operating activities -3.39M -3.80M -4.14M -3.15M -1.10M
Issuance of capital stock 0.55M - 0.00M 8.06M 0.00M
Depreciation 0.06M 0.07M 0.05M 0.05M 0.05M
Dividends paid 0.00M - - - 0.00M
Change to inventory - - 0.18M 0.03M 0.03M
Change to account receivables 0.03M 0.09M -0.18M -0.03M -0.10M
Other cashflows from financing activities - -0.02M - 3.88M 1.10M
Change to netincome - - - - 0.57M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.70M 0.45M -0.33M -0.46M 0.12M
Stock based compensation 0.68M 0.49M 0.80M 0.90M 0.39M
Other non cash items 0.18M 0.31M 0.22M -0.03M 0.20M
Free cash flow -3.39M -3.80M -4.14M -3.15M -1.10M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
VPT
VentriPoint Diagnostics Ltd		 -0.01
6.67%		 0.07 - - 107.72 7.13 120.70 -6.68
TLT
Theralase Technologies Inc.		 0.01
5.56%		 0.19 - - 90.07 82.51 90.31 -12.06
CNVI
Conavi Medical Corp.		 -0.01
4.35%		 0.11 - - 66.65 - 95.30 -
PINK
Perimeter Medical Imaging AI Inc		 -0.01
5.56%		 0.17 4.13 - 18.78 11.34 20.22 -2.55
CHER
Cheelcare Inc.		 -
-%		 1.25 - - 20.92 106.42 21.26 -

Profile*

VentriPoint Diagnostics Ltd

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.

18 Hook Avenue, Toronto, ON, Canada, M6P 1T4

416 848 4156

https://ventripoint.com

Name Title Year Born
Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D. Exec. Chairman & Interim CEO 1952
Mr. Victor Hugo C.M.A., CPA Chief Financial Officer 1970
Dr. Alvira Macanovic Ph.D. VP of Operations, Regulatory Affairs & Quality Assurance NA
Mr. Hirotaka Katagiri CTO & Bus. Devel. Division Director NA
Ms. Jessica Naman Director of Marketing NA
Mr. Desmond Hirson Consultant NA
Mr. Jim Graba Application Specialist & Chief Trainer NA
Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D. Executive Chairman & Corporate Secretary 1952
Mr. Hugh MacNaught Interim CEO, President & Director NA
Mr. Jimmy Jeon Chief Financial Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ORE
CAD 2.77
+8.86%
APM
CAD 4.95
+8.08%
NUAG
CAD 7.37
+8.06%
BZ
CAD 4.03
+8.04%
AYA
CAD 34.85
+7.96%
HUT
CAD 73.56
-17.26%
PHX
CAD 11.13
-12.22%
IVN
CAD 7.93
-10.70%
EFN
CAD 20.09
-10.39%
OBE
CAD 13.62
-6.71%

Equity Sectors*

  • Basic Materials

    +3.73%

  • Communication Services

    +1.16%

  • Consumer Cyclical

    +1.12%

  • Consumer Defensive

    +0.14%

  • Energy

    -1.87%

  • Financial Services

    +1.53%

  • Healthcare

    +1.50%

  • Industrials

    +0.03%

  • Real Estate

    +0.71%

  • Technology

    +0.40%

  • Utilities

    +0.35%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…